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have learnt that MMP inhibitors could produce side effects and
have not yet demonstrated a major reduction in the progression
of the disease. Certain MMPs, such as MMP-13 and ADAMTS
proteases, such as ADAMTS5, have been selected as being
the most attractive targets for the treatment of OA. The main
reason(s) for choosing selective inhibition, instead of a broad
inhibition, is based on the hypothesis that by doing so a certain
number of side effects that could potentially be related to a broad
MMP inhibition can be avoided.
Another possible way to inhibit the effect of certain catabolic
factors lies in the inhibition of certain intracellular signaling path-
ways such as the protein kinase cascades. The kinases, which
constitute the most appealing targets, include p38, ERK 1/2, and
SAPK/JNK. A recent study showed that an orally active ERK 1/2
selective inhibitors could very significantly and effectively reduce
the progression of lesions in the rabbit OA model by inhibiting the
synthesis of catabolic factors, such as MMPs. Another emerging
field of research focuses on the development of molecules that
can inhibit the binding of the transcription factors at the DNA
level. The major transcription factors targeted for the inhibition of
cytokines and MMP synthesis are NF-κB and AP-1.
On the subject of cell signaling, another interesting target are the
ligands to a group of nuclear transcription factors, the peroxisome
proliferator-activated receptor gamma (PPARγ), which act as
anti-inflammatory agents. In vivo, synthetic PPARγ ligands were
found to protect against structural damages in the collagen-
induced arthritis model and in OA models.
OA structural changes also involve modifications in the mor-
phology of the surrounding bone. Subchondral bone remodeling
is a well-recognized manifestation of OA. New data underline
the concept that abnormal subchondral bone cell functions may
contribute to the onset/progression of OA. Therapeutic effects
of drugs that prevent the abnormal metabolism of subchondral
osteoblasts on the progression of OA lesions is currently of major
interest in the context of future DMOAD development.
Several new pharmacologic DMOAD agents are under inves-
tigation. Preclinical results are promising and demonstrate the
possibility of retarding or inhibiting the progression of joint tissue
structural changes. The tools to study such effects in the human
population remain unsatisfactory. Existing radiologic methods
are useful but this methodology is imperfect and time consum-
ing. Faster and more accurate methods are needed to improve
the investigation of new drugs that have the potential to modify
the progression of OA.
In conclusion, several interesting new approaches for the treat-
ment of this disease are now being explored. New classes of
molecules that inhibit one or more of the disease processes of
OA are under evaluation for their potential to alter the degenera-
tive process
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BIOREACTORS FOR CARTILAGE TISSUE
ENGINEERING
Ivan Martin
Introduction: Recent animal experiments have demonstrated
that engineered cartilage tissues generated by culturing chon-
drocytes into 3D scaffolds provide functional templates for the
orderly repair of critically sized osteochondral lesions. In order to
reproducibly generate functional cartilage tissues starting from
adult human cells, efforts have to be directed not only to the
identification of stimulatory biochemical factors, but also to the
development and use of controlled bioreactor systems, applying
defined regimes of physical forces. In this work, we present some
examples on the use of bioreactors for processes that are key for
engineering of 3D cartilage tissues based on cells and scaffolds,
namely the chondrocyte seeding into porous scaffolds, their ef-
ficient nutrition, and the pysical conditioning of the developing
tissues.
Chondrocyte seeding and culture under perfusion: In the cell
seeding process, cells must be utilized with maximum efficiency
to minimize the biopsy size needed and/or the extent of cell
expansion, and must be dispersed uniformly throughout the
scaffold volume to form the basis for uniform tissue formation.
To overcome limitations associated with the most commonly
employed seeding techniques, we developed a bioreactor for
the automated cell seeding of three-dimensional scaffolds by
continuous perfusion of a cell suspension through the scaffold
pores in oscillating directions. Perfusion seeding of chondrocytes
into Polyactive foams (IsoTis OrthoBiologics, NL) or Hyaff?-11
non-woven meshes (Fidia Advanced Biopolymers, IT) resulted
in the highest fraction of viable cells within the foam pores, the
greatest efficiency of seeding and the highest uniformity of cell
distribution in comparison to the typically used static and spinner
flask methods [1].
Constructs uniformly seeded by perfusion and then cultured
statically for 2 weeks were highly heterogeneous in structure,
consisting of a layer of cells and matrix at the periphery and an
essentially void interior region. Instead, constructs cultured under
prolonged perfusion were remarkably homogeneous, containing
a uniform distribution of both cells and matrix throughout the
cross-section [2].
Physical conditioning of cartilagel constructs: Application of
dynamic compression to cell-polymer constructs could poten-
tially improve the development of cartilaginous tissue in vitro.
We exposed human articular chondrocytes-based cartilaginous
constructs at different stages of maturation, as defined by the
glycosaminoglycan (GAG) content, to intermittent compressive
deformation for 3 days. Compression-induced changes in GAG
synthesis and accumulation were positively correlated to the
GAG content prior to loading, such that compression was stimu-
latory only for the most developed constructs. Therefore, under
our experimental conditions, cyclic loading appears to be appli-
cable for the enhancement of cartilaginous tissue development
only in the late phases of tissue regeneration [3]. Our results
also point out the possible use of bioreactors applying defined
regimes of physical forces as a quality control tool for engineered
cartilage, with the goal of defining when the tissues are suffi-
ciently developed for immediate load bearing after implantation.
Conclusion: The reviewed studies indicate that bioreactors en-
able generation of cartilaginous tissue constructs and may con-
tribute to understand the function of specific chemico-physical
culture parameters on cartilage tissue development. In the fu-
ture, bioreactors are expected to efficiently translate laboratory-
to inductrial-scale cartilage tissue engineering, possibly providing
an economically viable approach to the automated manufacture
of functional cartilage grafts for broad clinical use [4].
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PAIN IN OSTEOARTHRITIS
Hans-Georg Schaible
Purpose: The most dominant subjective problem of the patient
suffering from osteoarthritis is pain. In most cases pain is local-
ized to the joint with OA but it can be referred to other joints.
OA pain varies in intensity and is usually worsened by exercise
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and relieved at rest. Some patients suffer from pain at night.
OA pain is often episodic but may be constant in advanced
OA. Often there is a poor relationship between pain and joint
damage as assessed by X-ray, but some MRI studies revealed
that painful osteoarthritic joints show more MRI-abnormalities
such as synovial hypertrophy, synovial effusions and bone mar-
row edema lesions. Furthermore chronic inflammatory changes
can be present. Finally, self-reported pain is often influenced by
perceived helplessness, educational, social and psychological
factors showing the complexity of chronic pain. To approach the
pain problem it is necessary to study the principles of nociception
in the joint, the processing of nociceptive sensory input from the
joint in the central nervous system and the neuronal processes
in the thalamocortical system that generate the pain response
with its sensory and affective components.
Methods: In order to investigate pain mechanisms numerous
methods are being used including morphological methods to
visualize nerve fibres, electrophysiological methods to record
from nociceptive neurons in the peripheral and central nervous
system and approaches to assess pain behaviour. In humans
brain imaging techniques are widely used to show the activity in
the so-called thalamocortical pain matrix.
Results: Although osteoarthritis is a disease of cartilage it is
unlikely that pain arises from nociceptive stimulation of carti-
lage itself because cartilage does not seem to be innervated.
It is thought, therefore, that the pain is generated by nocicep-
tive stimulation of nerve fibres in capsule, menisci, ligaments
and subchondral bone. At these sites sensory endings of thin
myelinated A delta- and unmyelinated C-fibres have been visu-
alized. Electrophysiological recordings from nerve fibres in the
joint nerve have revealed the response properties of A-delta and
C-fibres to noxious stimuli. Nociceptive joint afferents are either
polymodal responding to noxious mechanical stimuli and to me-
diators such as inflammatory mediators or they are silent not
responding to mechanical stimulation under normal conditions.
Importantly, nociceptive nerve fibres can be sensitized during
pathological processes such as inflammation which results in
enhanced responsiveness of polymodal nociceptors to mechan-
ical stimulation (lowering of threshold, enhanced responses to
suprathreshold stimuli) and in the induction of mechanosensitivity
of silent nociceptors. Key to sensitization is the chemosensitiv-
ity of joint afferents. A-delta and C-fibres express receptors for
numerous mediators that play an important role in processes
of joint inflammation and osteoarthritis such as prostaglandins,
bradykinin, cytokines and others. Inflammatory mediators acti-
vate second messenger systems in neurons that influence ion
channels involved in stimulus transduction. Receptors in sensory
nerve fibres can be upregulated under acute and chronic painful
conditions. This process of peripheral sensitization can induce
a state of central sensitization. An important amplification of the
nociceptive processing through the process of central sensiti-
zation takes place in the spinal cord. Data from OA patients
indicate that central sensitization is present in painful OA states.
Ascending tracts convey the information from the spinal cord to
the thalamocortical system where the conscious pain response
is generated. Imaging data emphasize the existence of two sys-
tems that are involved in pain. The lateral thalamocortical system
consisting of lateral thalamic relay nuclei and the cortical areas
S1 and S2 produces the sensory discriminative pain response
analysing the site, intensity and duration of painful stimuli. The
medial thalamocortical system consisting of medial thalamic nu-
clei and cortical areas in the insula, the anterior cingulate gyrus
and the prefrontal cortex produces the affective pain response
which causes the suffering from pain.
Conclusions: OA pain under activated conditions such as acute
episodes of inflammation or chronic inflammatory conditions is
likely to result from peripheral and central sensitization. Whether
additional mechanisms such as damage of nerve fibres and
elements of neuropathic pain contribute to OA pain is being
explored. Future progress in the understanding of OA pain is
expected from techniques that allow to correlate pathological
changes in the diverse joint structures with the experience of
pain and from the work on experimental models that are relevant
for human OA.
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NEW METHODS FOR MOLECULAR DISCOVERY IN
OSTEOARTHRITIS: A FOCUS ON CELL SIGNALING
Richard F. Loeser Jr.
A better understanding of basic molecular mechanisms that reg-
ulate cartilage matrix destruction is needed in order to develop
new treatments for osteoarthritis that have the potential to slow
disease progression. It is well accepted that the chondrocyte is
responsible for the progressive destruction and loss of its own
matrix through the release of degradative enzymes accompa-
nied by an inadequate repair response. This appears to result
from an imbalance in chondrocyte anabolic and catabolic activity.
Studies on the cell signaling pathways in chondrocytes that regu-
late anabolic and catabolic activity, including the effects of aging
on these pathways, should define novel targets for correcting
the imbalance. Genomics approaches have defined numerous
genes that are up or downregulated in OA chondrocytes when
compared to chondrocytes from normal joints. Expression of
many of these genes may be regulated by a common set of
key signaling intermediates that are activated in response to
stimulation of chondrocytes by cytokines and by signals from
the matrix mediated by the integrin family of receptors. Phos-
phorylation of specific tyrosine, serine and threonine residues
mediated by kinases is a common mechanism for propagation of
intracellular signals. Recently, the role of reactive oxygen species
(ROS) as secondary messengers in cell signaling has become
better understood. The reversible oxidation of specific cysteine
residues to cysteine sulfenic acid acts to regulate the activity of
many signaling proteins including kinases and phosphatases. In
this workshop, cell signaling pathways relevant to the regulation
of chondrocyte anabolic and catabolic activity will be reviewed
with a focus on the methodologies used to study signal trans-
duction. Advantages and pitfalls of various methodologies will be
discussed with the goal of facilitating an interactive discussion
on new methods that can be used to better understand basic
molecular mechanisms regulating chondrocyte function.
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MRI IN OSTEOARTHRITIS, USEFUL FOR THE
RESEARCHER AND CLINICIAN
Philip G. Conaghan
Magnetic resonance imaging (MRI) provides unparalleled ability
to visualise all the structures involved in the whole-organ joint
failure process that is osteoarthritis (OA). For the researcher it
provides a new level of in vivo understanding of the key tissue
pathology. The majority of MRI OA studies to date have focussed
on the knee joint. Large cohort studies have demonstrated fre-
quent abnormalities of cartilage, menisci, bone (bone marrow
lesions, BML, and osteophytes), even when there is minimal
radiographic abnormalities.
An important basic requirement for the researcher is valid meth-
ods of quantifying this joint pathology. Quantitative measures of
cartilage and semi-quantitative score systems for all the knee
structural features have been developed, and increasing data
on their validity, reliability and sensitivity to change have been
published over the last few years.
The next step is to understand the importance of these MRI
